Antibody Persistence in the Six Months Following SARS-CoV-2 Infection Among Hospital Workers
Arnaud G. L’Huillier, Laurent Kaiser(University Hospital of Geneva), Isabella Eckerle(University of Geneva), Sabine Yerly(Unknown), Christiane S. Eberhardt(University of Geneva), Klara M. Posfay‐Barbe(University Hospital of Geneva), Claire‐Anne Siegrist(University of Geneva), Carole Grasset-Salomon(University of Geneva), Stéphanie Baggio(University of Bern), Isabelle Arm‐Vernez(University of Geneva), Angela Huttner(University Hospital of Geneva), Nicolas Vuilleumier(University of Geneva), Jacques A. Pralong(University of Geneva), Benjamin Meyer(University of Geneva), Arnaud M. Didierlaurent(University of Geneva), Irène Sabater Royo(University of Geneva), Diego O. Andrey(University of Geneva)
Cited by 3
Related Papers
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
|The Journal of Immunology|2009|739
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
|New England Journal of Medicine|2015|412
Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection
|The Journal of Experimental Medicine|2008|390